Literature DB >> 1475026

Effects of cholinergic agonists on regional brain energy metabolism in the scopolamine-treated rat.

C A Ray1, J Blin, T N Chase, M F Piercey.   

Abstract

The effects of scopolamine, physostigmine, RS86 and U-80816B on regional energy metabolism were studied in rodents by means of the 2-deoxyglucose autoradiographic technique. Scopolamine depressed metabolism in an area of cerebral cortex, focused around the parietal region. Rats treated with cholinergic direct agonists (U-80816B, RS86) as well as with the indirect agonist (physostigmine) all showed decreases in cortical energy metabolism, similar to scopolamine. They also induced an increase in thalamic metabolism. When these drugs were given in conjunction with scopolamine, metabolism tended to change in the opposite direction from the values obtained with the drug alone. These results suggest that there are complex interactions between pre- and post-synaptic muscarinic receptors. Additionally, nicotinic receptors could also be involved in some of the effects of physostigmine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1475026     DOI: 10.1016/0028-3908(92)90017-j

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  4 in total

1.  Piracetam prevents scopolamine-induced memory impairment and decrease of NTPDase, 5'-nucleotidase and adenosine deaminase activities.

Authors:  Patricia C Marisco; Fabiano B Carvalho; Michelle M Rosa; Bruna A Girardi; Jessié M Gutierres; Jeandre A S Jaques; Ana P S Salla; Víctor C Pimentel; Maria Rosa C Schetinger; Daniela B R Leal; Carlos F Mello; Maribel A Rubin
Journal:  Neurochem Res       Date:  2013-05-16       Impact factor: 3.996

2.  Mecamylamine reverses physostigmine-induced attenuation of scopolamine-induced hyperactivity.

Authors:  M F O'Neill; A G Fernández; R W Gristwood; J M Palacios
Journal:  J Neural Transm Gen Sect       Date:  1994

3.  The effect of the muscarinic antagonist scopolamine on regional cerebral blood flow during the performance of a memory task.

Authors:  P M Grasby; C D Frith; E Paulesu; K J Friston; R S Frackowiak; R J Dolan
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

4.  Neuroprotective Effects of AMP-Activated Protein Kinase on Scopolamine Induced Memory Impairment.

Authors:  Soo-Jeong Kim; Jun-Ho Lee; Hwan-Suck Chung; Joo-Hyun Song; Joohun Ha; Hyunsu Bae
Journal:  Korean J Physiol Pharmacol       Date:  2013-07-30       Impact factor: 2.016

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.